Evaluation of corneal endothelial cell loss following vitrectomy with different endotamponades
- PMID: 40666788
- PMCID: PMC12258856
- DOI: 10.4103/ojo.ojo_258_24
Evaluation of corneal endothelial cell loss following vitrectomy with different endotamponades
Abstract
Context: Ensuring functional corneal endothelium is imperative for achieving optimal surgical outcomes following successful vitreoretinal surgery. Despite the critical role of the corneal endothelium in postoperative recovery, limited research has addressed endothelial cell damage specifically attributed to vitreoretinal procedures. This knowledge gap necessitates further investigations to better understand the potential loss of corneal endothelial cells (CECs) associated with vitreoretinal surgery.
Aims: To evaluate the effect of vitreoretinal surgery on CECs by using different endotamponading agents.
Settings and design: Prospective, nonrandomized, comparative, and observational study.
Subjects and methods: Patients (n = 32) were divided into three groups: C3F8 gas (Group A), silicone oil (Group B), and Ringer Lactate (Group C). Corneal endothelial parameters including, the corneal endothelial cell density (ECD), average cell area (AVG), coefficient of variation (CV), central corneal thickness (CCT), and percentage of hexagonal cells (HEX) were assessed preoperatively, at 1 month, and 3 month postsurgery.
Statistical analysis used: SPSS software version 16.0, Kolmogorov-Smirnov, Wilcoxon, and Chi-square tests were used. Statistical significance was set at P < 0.05.
Results: Significant differences in the changes in ECD and CCT were observed between the groups (P > 0.05). However, AVG, CV and HEX were not significantly different between the groups. No significant differences in the changes in endothelial cell parameters were noted between phakic and pseudophakic eyes.
Conclusions: CEC damage following vitrectomy with different endotamponades is a crucial consideration in vitreoretinal surgery. Vitreoretinal surgeons must carefully weigh the benefits and risks associated with different tamponade agents to safeguard corneal health in vitreoretinal surgeries.
Keywords: Corneal endothelial cell; endotamponading agent; vitreoretinal surgery.
Copyright: © 2025 Oman Ophthalmic Society.
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Choi JY, Han YK. Long-term (≥10 years) results of corneal endothelial cell loss after cataract surgery. Can J Ophthalmol. 2019;54:438–44. - PubMed
-
- Ibrahim SF, Zaki HA, Dabour SA, Eid AM. Corneal endothelial cell changes after pars plana vitrectomy silicone versus non silicone filled eyes. Zagazig Univ Med J. 2022;28:239–44.
-
- Yang CS, Chen KH, Hsu WM, Li YS. Cytotoxicity of silicone oil on cultivated human corneal endothelium. Eye (Lond) 2008;22:282–8. - PubMed
-
- Rosenfeld SI, Waltman SR, Olk RJ, Gordon M. Comparison of intraocular irrigating solutions in pars plana vitrectomy. Ophthalmology. 1986;93:109–15. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous